ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

INFI Infinity Pharmaceuticals Inc

0.0322
0.00 (0.00%)
17 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
Infinity Pharmaceuticals Inc NASDAQ:INFI NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 0.0322 0.0321 0.0348 0 01:00:00

Infinity To Present At BIO Investor Forum

11/10/2018 1:32pm

PR Newswire (US)


Infinity Pharmaceuticals (NASDAQ:INFI)
Historical Stock Chart


From May 2019 to May 2024

Click Here for more Infinity Pharmaceuticals Charts.

CAMBRIDGE, Mass., Oct. 11, 2018 /PRNewswire/ -- Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) will be presenting at the BIO Investor Forum on Wednesday, October 17, 2018, at 11:15 a.m. PT (2:15 p.m. ET) in San Francisco, CA. A live webcast of the presentation will be available on the Investors/Media section of Infinity's website at www.infi.com, and will be available for 30 days following the event.

About Infinity
Infinity is an innovative biopharmaceutical company dedicated to advancing novel cancer treatments. Infinity is advancing IPI-549, a potentially transformative immuno-oncology approach that aims to reprogram tumor-associated macrophages by selectively inhibiting PI3K-gamma. A Phase 1/1b study in approximately 200 patients with advanced solid tumors is ongoing. For more information on Infinity, please refer to Infinity's website at www.infi.com.

Contact:
Stephanie Ascher, Stern Investor Relations, Inc.
212-362-1200 or Stephanie@sternir.com

Cision View original content:http://www.prnewswire.com/news-releases/infinity-to-present-at-bio-investor-forum-300729176.html

SOURCE Infinity Pharmaceuticals, Inc.

Copyright 2018 PR Newswire

1 Year Infinity Pharmaceuticals Chart

1 Year Infinity Pharmaceuticals Chart

1 Month Infinity Pharmaceuticals Chart

1 Month Infinity Pharmaceuticals Chart